Biohaven Busy Work

I saw the commercial last night. Fake news.

 

But it’s not fake news that we have way too many reps.

 

Kicking ass!! That’s what we’re doing

 

that was always the plan. Launch big, try to circumvent current habits of migraine specialists by bombarding the next tier down and then cut back when it made sense.

this lockdown just changes the strategy and the pace.

 

“This drug is going to change the market” Seriously? Every single company that comes out with some pricey new drug says this. “Oh, it’s a game changer!!” and “This drug is going to change the treatment of XYZ disease state!!” You need to put down the Kool Aid and get real. It’s not going to change anything. Docs will keep reaching for generics because that’s what they are being told to do by managed care. Managed Care controls everything. It’s all about the bottom line. I don’t know what the future holds for the pharma industry. We need the innovation they bring to the treatment of disease. But it’s useless if doctors won’t write the drugs because they are expensive, require PA’s, and they get penalized by managed care for writing branded drugs.

 

You make too much sense. If a company cannot get their drug onto large formularies at a reasonable price then sorry- not a good formula for success.

 

The new model is to give away the product for 6-9 months to drive clinical experience for providers and patients. Company can then license use to managed care companies.

 

our formulary success has been great - thanks Biohaven MC reps!!

 

Yeah, that’s what happens when you are willing to give up 50-60% GTN for a contract.

all the more reason having the number of reps isn’t necessary or sustainable.

 

There are more drugs in the pipeline.

 

Yeah a lot of us came on board with this golden carrot dangled in front of us, but reality has now set in, and we realize that any approvals are a couple of years down the road. Plus no bipolar drug. Then the pandemic hit the week of launch, plus they’re giving away a huge portion of scripts with savings card. I don’t know how this company can sustain all of these reps. Don’t misunderstand me, I hope they can. But I really don’t know how it’s possible

 

None of which require this footprint.

 

look at it this way, we are carrying a $125-$145 Million field force cost.

unless this drug does $1 billion, no CFO is going to let that slide for too long.

 

There’s no reason to think we can’t eventually got to a billion with Nurtec. If each territory averages 200 patients per year on drug at a AWP of $850 per month, that’s $2 million per territory. If we have 300 territories, that’s $600 million. I’m not saying we get there this year, but it’s totally doable.

 

That's a high AWP for this product

 

OK, now throw in rebates of 40-50% to get any kind of payer coverage and you can cut your revenue in half.

Not many migraine drugs out there that hit $1 billion.

 

Yep it was the migraine drug + the pipeline..

 

Stay calm and keep your jammies on.

 

How many Rxs are territories averaging?

 

In our district 1-15 a week